FDA warning on antidepressants and suicidal behavior


Dear fellow psychiatrists,

The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).

Source:
US Food and Drug Administration

More videos/news article:
FDA Orders Antidepressant Warning
FDA: Antidepressant Warning Suicide Watch
FDA seeks new antidepressant warning

Do I smell something fishy here? Well, as usual silence is golden

No comments:

Post a Comment